Cumberland Pharmaceuticals (CPIX) Assets Average (2011 - 2026)

Cumberland Pharmaceuticals has disclosed Assets Average across 16 years of filings, most recently posting $73.9 million for Q1 2026.

• Assets Average for Q1 2026 came in at $73.9 million, up 1.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $73.9 million (up 1.58% YoY), and the FY2025 annual result was $76.2 million, down 3.15% from the prior year.
• Assets Average came in at $73.9 million for Q1 2026 at Cumberland Pharmaceuticals, up from $71.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $94.6 million in Q2 2022 to a low of $66.9 million in Q3 2025.
• The 5-year median for Assets Average is $81.6 million (2024), against an average of $81.9 million.
• Across the five-year window, Assets Average climbed 6.78% in 2022 and slipped 13.86% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Assets Average stood at $91.9 million in 2022, then decreased by 7.72% to $84.8 million in 2023, then declined by 10.14% to $76.2 million in 2024, then decreased by 6.31% to $71.4 million in 2025, then climbed by 3.57% to $73.9 million in 2026.
• The last three Assets Average figures came in at $73.9 million (Q1 2026), $71.4 million (Q4 2025), and $66.9 million (Q3 2025), per Business Quant data.